Literature DB >> 12872014

Multiple sclerosis: severity and progression rate in African Americans compared with whites.

Michael D Kaufman1, Susan K Johnson, David Moyer, Jessica Bivens, H James Norton.   

Abstract

OBJECTIVE: Although epidemiology indicates that multiple sclerosis is more common among whites than African Americans, the course of disease may be more aggressive among African Americans. This study examines disease course in a large multiple sclerosis clinic population.
DESIGN: A case-controlled, retrospective record review compared the severity of multiple sclerosis for African Americans and for whites. Because the baseline demographics of the two groups differed, we performed analyses of multiple subgroups in an attempt to control for various characteristics.
RESULTS: Consistent evidence of more disability in African Americans compared with whites was found, although subgroups were often too small to establish statistical significance. African Americans had a higher mean Expanded Disability Status Scale score than whites in a subgroup selected to minimize differences in access to care and disease perceptions. African Americans reported limb weakness as a presenting symptom of multiple sclerosis more frequently than did whites. When patients were followed at our multiple sclerosis center, rates of disease progression were nearly identical.
CONCLUSIONS: More African Americans than whites experience pyramidal system involvement early in multiple sclerosis, leading to greater disability as measured by the ambulation-sensitive Expanded Disability Status Scale. Once patients have moderate difficulty walking, the rate of progression is the same for both groups, albeit occurring at a later age for whites than for African Americans.

Entities:  

Mesh:

Year:  2003        PMID: 12872014     DOI: 10.1097/01.PHM.0000078199.99484.E2

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  18 in total

1.  Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.

Authors:  Natalia Gonzalez Caldito; Shiv Saidha; Elias S Sotirchos; Blake E Dewey; Norah J Cowley; Jeffrey Glaister; Kathryn C Fitzgerald; Omar Al-Louzi; James Nguyen; Alissa Rothman; Esther Ogbuokiri; Nicholas Fioravante; Sydney Feldman; Ohemaa Kwakyi; Hunter Risher; Dorlan Kimbrough; Teresa C Frohman; Elliot Frohman; Laura Balcer; Ciprian Crainiceanu; Peter C M Van Zijl; Ellen M Mowry; Daniel S Reich; Jiwon Oh; Dzung L Pham; Jerry Prince; Peter A Calabresi
Journal:  Brain       Date:  2018-11-01       Impact factor: 13.501

2.  Retinal damage and vision loss in African American multiple sclerosis patients.

Authors:  Dorlan J Kimbrough; Elias S Sotirchos; James A Wilson; Omar Al-Louzi; Amy Conger; Darrel Conger; Teresa C Frohman; Shiv Saidha; Ari J Green; Elliot M Frohman; Laura J Balcer; Peter A Calabresi
Journal:  Ann Neurol       Date:  2015-01-13       Impact factor: 10.422

3.  Efficacy and tolerability of dimethyl fumarate in White-, African- and Hispanic- Americans with multiple sclerosis.

Authors:  Lana Zhovtis Ryerson; Rivka Green; Gladyne Confident; Krupa Pandey; Benjamin Richter; Tamar Bacon; Carrie Sammarco; Lisa Laing; Jennifer Kalina; Ilya Kister
Journal:  Ther Adv Neurol Disord       Date:  2016-08-04       Impact factor: 6.570

Review 4.  First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks.

Authors:  Jacqueline Ann Nicholas; Michael Karl Racke; Jamie Imitola; Aaron Lee Boster
Journal:  Ther Adv Chronic Dis       Date:  2014-03       Impact factor: 5.091

5.  Demyelinating events in early multiple sclerosis have inherent severity and recovery.

Authors:  E M Mowry; M Pesic; B Grimes; S Deen; P Bacchetti; E Waubant
Journal:  Neurology       Date:  2009-02-17       Impact factor: 9.910

6.  Spinal cord lesions and disability in Hispanics with multiple sclerosis.

Authors:  L Amezcua; A Lerner; K Ledezma; D Conti; M Law; L Weiner; A Langer-Gould
Journal:  J Neurol       Date:  2013-08-03       Impact factor: 4.849

7.  Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis.

Authors:  Yujie Wang; Fan Tian; Kathryn C Fitzgerald; Jagriti Jackie Bhattarai; Robert T Naismith; Megan Hyland; Peter A Calabresi; Ellen M Mowry
Journal:  Mult Scler Relat Disord       Date:  2020-02-14       Impact factor: 4.339

8.  Clinical predictors of early second event in patients with clinically isolated syndrome.

Authors:  Ellen M Mowry; Mila Pesic; Barbara Grimes; Serina R Deen; Peter Bacchetti; Emmanuelle Waubant
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

9.  Muscle Dysfunction and Walking Impairment in Women with Multiple Sclerosis.

Authors:  T Bradley Willingham; Deborah Backus; Kevin K McCully
Journal:  Int J MS Care       Date:  2019 Nov-Dec

10.  Beneficial effects of UV radiation other than via vitamin D production.

Authors:  Asta Juzeniene; Johan Moan
Journal:  Dermatoendocrinol       Date:  2012-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.